Impedimed

Impedimed

  • Founded in 2008
  • 51-200 Employees
  • $1.1M Post-IPO Debt on 2020-05

Careers at Impedimed


About Impedimed

ImpediMed is a company specializing in digital health technologies for the early detection and management of lymphedema, particularly in breast cancer patients. The company offers the SOZO Digital Health Platform, which is an FDA-cleared bioimpedance spectroscopy (BIS) solution for assessing clinical lymphedema. ImpediMed focuses on improving patient outcomes by partnering with healthcare providers to implement Lymphedema Prevention Programs. Their technology helps detect lymphedema in its early stages, preventing it from progressing to a chronic condition.